News

CD52-stabilization as a potential target for immunotherapy in liver cirrhosis. (Symbolic image: ChatGPT)

/ News, Research

Unveiling CD52 on monocytes: A New Frontier in Combating Immune Dysfunction in Cirrhosis (Bernsmeier Lab)

The Department of Biomedicine (DBM) is pleased to announce an important new study led by Anne Geng, under the supervision of Christine Bernsmeier, in collaboration with researchers at the University Hospital Basel and colleagues in St.…
Swiss Cancer Research and League

/ News, Research

Advancing Cancer Research: Our Scientists Secure Prestigious Grant for Groundbreaking Project

The Swiss Cancer Research Foundation and the Swiss Cancer League have recently announced the recipients of their latest funding round, awarding grants to 55 outstanding research projects in various categories. We are proud to announce that…
.

/ News, Other

For better leukemia therapies: spin-off Cimeio partners with pharmaceutical company Kyowa Kirin (Jeker Lab)

Start-up Cimeio Therapeutics intends to pave the way for gentler and more efficient treatments for diseases such as blood cancer. The company, a spin-off of the University of Basel, has just concluded an important collaboration agreement:…
.

/ News, People

Prestigious award for multiple sclerosis research: Sobek Foundation Award 2024 for Jens Kuhle (Clinical Neuroimmunology Lab)

The Sobek Foundation has honored outstanding achievements in multiple sclerosis (MS) research with its prestigious 2024 Award. The 100,000 Euro Sobek Research Prize, Europe’s most valued award for MS research, has been awarded to Prof. Dr.…
Valérie Hilgers receives an ERC Consolidator Grant

/ News, People

Valérie Hilgers receives prestigious ERC Consolidator Grant for groundbreaking neurogenetic research using fruit flies and mini-brains

The DBM is thrilled to announce that Valérie Hilgers, newly appointed Professor of Anatomy and Cell Biology, has been awarded a prestigious Consolidator Grant from the European Research Council (ERC). This highly competitive grant will…